Predictive tools mimicking disease progression & treatment efficacy

Design and implementation of precision medicine clinical trials including gut microbiota
30/10/2019
End-to-end microbiota offering powered by Biofortis
06/11/2019

Predictive tools mimicking disease progression & treatment efficacy

Human cancer in vitro models for pre-clinical oncology drug development.

About 40 defined in vitro cells models (Breast, Ovary, Prostate, Lungs, Liver, Lymphoma, Pancreas) from both highly characterized primary tumor cells and from PDX are available in the IMODI webcatalogue.
Models are available at low passages to better reflect the properties of patient tumors and tumoral heterogeneity and offer an innovative integrated path for drug screening and development, understanding of the mechanism of action and evaluation of efficacy while providing an easy transfer to preclinical trials

CTIBiotech can also help you develop customized in-vitro cell model and assay, including for immunotherapy against cancer and tumour microenvironment targeting.

CTIBioTumour: human microtumours produced by 3D-bioprinting to fast-track new cancer therapies.

CTIBioTumour accurately reproduces, in vitro, the interactions between human cancer cells and other types of cells that form the tumor microenvironment, including with IMODI in-vitro models. 3D-Bioprinted microtumours can be produced for medium- and high-throughput pre-clinical studies.

Please contact CTIBiotech at office@ctibiotech.com for more information about these models:

About 40 defined in vitro cells models. Access our webcatalogue

Breast

Breast

Ovary

Ovary no txt

Pancreas

Pancreas no txt

Lungs

Lungs no txt

Lymphoma

Lymphoma no txt

Liver

Liver no txt

Prostate

Prostate
Share this